Individual Parallel Consultations are supported by the EUnetHTA ED Secretariat, thereby benefiting from HTA scientific and administrative coordination with centralised HTA recruitment, consolidated HTA comments and List of Issues, albeit with individual HTA written reports as the final product.
It refers to the parallel consultation between European Network for Health Technology Assessment (EUnetHTA) and the European Medicines Agency (
Leadership in meaningful innovation. We provide innovative product development with tailored solutions to the most challenging problems.
Join us at key industry conferences to meet the experts and have a comprehensive view on how to optimize your product development.
Educational resources to help you better understand the regulatory environment, new regulations and much more.
Protocol assistance is the special form of scientific advice available for companies developing designated orphan medicines for rare diseases.
A TPP is a format for a summary of a drug development program described in terms of labeling concepts.